Centiva Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-26,473
| Closed | -$398K | – | 1712 |
|
2024
Q3 | $398K | Buy |
+26,473
| New | +$398K | 0.01% | 936 |
|
2023
Q1 | – | Sell |
-6,512
| Closed | -$251K | – | 1282 |
|
2022
Q4 | $251K | Buy |
+6,512
| New | +$251K | 0.01% | 657 |
|
2021
Q4 | – | Sell |
-7,461
| Closed | -$417K | – | 1025 |
|
2021
Q3 | $417K | Buy |
+7,461
| New | +$417K | 0.03% | 552 |
|